Glutathione and cellular response of ACNU-resistant rat glioma sublines to drugs and radiation

Int J Cancer. 1991 Jul 30;48(6):861-5. doi: 10.1002/ijc.2910480612.

Abstract

Three ACNU-resistant sublines (R1, R3 and R12) from rat glioma 9L cells showed cross-resistance to vinblastine, adriamycin, and VP-16. Among these, the R3 subline also acquired radioresistance under aerobic conditions. Total glutathione levels in these sublines were elevated 2- to 3-fold. Treatment of the cells with BSO, a specific inhibitor of GSH synthesis, resulted in decreased intracellular total glutathione levels in all 4 cell lines to about 10% of control levels. However, sensitivity to radiation or to chemicals did not change accordingly. Treatment of 9L cells with OTZ, a precursor of cysteine, resulted in a rise in intracellular GSH levels but it did not correlate with sensitivity to X-ray or to ACNU. These results suggest that, in terms of cellular sensitivity to radiation or ACNU, total glutathione level alone cannot serve as a predictive indicator.

MeSH terms

  • Animals
  • Buthionine Sulfoximine
  • Cell Line
  • Cell Survival / drug effects*
  • Cell Survival / radiation effects
  • Dose-Response Relationship, Radiation
  • Doxorubicin / pharmacology*
  • Drug Resistance
  • Etoposide / pharmacology*
  • Glioma
  • Glutathione / metabolism*
  • Kinetics
  • Methionine Sulfoximine / analogs & derivatives
  • Methionine Sulfoximine / pharmacology
  • Nimustine / pharmacology*
  • Pyrrolidonecarboxylic Acid
  • Rats
  • Thiazoles / pharmacology
  • Thiazolidines
  • Vinblastine / pharmacology*

Substances

  • Thiazoles
  • Thiazolidines
  • Nimustine
  • Methionine Sulfoximine
  • Buthionine Sulfoximine
  • Vinblastine
  • Etoposide
  • Doxorubicin
  • Glutathione
  • Pyrrolidonecarboxylic Acid
  • 2-oxothiazolidine-4-carboxylic acid